Stock Rich List
Nasdaq: RARE

Ultragenyx Pharmaceutical insiders

The officers, directors and 10% owners of Ultragenyx Pharmaceutical Inc. who hold the most stock, valued at the live RARE price.

$17.22
RARE today −$510K (−2.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
3
Their RARE stock
$85.5M
Market value
$1.76B
Held by ranked insiders
4.87%

Insiders by value of RARE holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Emil D. KakkisPresident & CEO4,853,709$83.6M4.76%1715th
2Mardi DierCFO & Executive Vice President66,695$1.1M<0.1%12612th
3Camille L. BedrosianEVP and Chief Medical Officer46,720$805K<0.1%9589th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ultragenyx Pharmaceutical; see each profile for the filing.